Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Non Operating Investment Income (2022 - 2025)

Pediatrix Medical (MD) has disclosed Non Operating Investment Income for 4 consecutive years, with $164000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Non Operating Investment Income rose 119.03% to $164000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 million, a 47.07% increase, with the full-year FY2025 number at $1.7 million, up 47.07% from a year prior.
  • Non Operating Investment Income was $164000.0 for Q4 2025 at Pediatrix Medical, down from $309000.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $1.7 million in Q3 2024 to a low of -$2.7 million in Q1 2022.
  • A 4-year average of $129000.0 and a median of $200000.0 in 2024 define the central range for Non Operating Investment Income.
  • Biggest YoY gain for Non Operating Investment Income was 174400.0% in 2024; the steepest drop was 166.16% in 2024.
  • Pediatrix Medical's Non Operating Investment Income stood at -$2.7 million in 2022, then soared by 148.84% to $1.3 million in 2023, then crashed by 166.16% to -$862000.0 in 2024, then soared by 119.03% to $164000.0 in 2025.
  • Per Business Quant, the three most recent readings for MD's Non Operating Investment Income are $164000.0 (Q4 2025), $309000.0 (Q3 2025), and $429000.0 (Q2 2025).